Acorda Therapeutics (United States)

Recent papers from Acorda Therapeutics (United States)

1. Addendum: Exploring the Importance of Race and Gender Concordance Between Patients and Physical Therapists in Digital Rehabilitation for Musculoskeletal Conditions: Observational, Longitudinal StudyJournal of Medical Internet Research · 2026
2. Addendum: Impacts of Digital Care Programs for Musculoskeletal Conditions on Depression and Work Productivity: Longitudinal Cohort StudyJournal of Medical Internet Research · 2026
3. Addendum: Managing Musculoskeletal Pain in Older Adults Through a Digital Care Solution: Secondary Analysis of a Prospective Clinical StudyJMIR Rehabilitation and Assistive Technologies · 2026
4. Targeting cfDNA and NETs with DNAse I to augment CAR T-cell function and antitumor efficacy.Journal of Clinical Oncology · 2026
5. Abstract 415: Combination of VLS-1488 and taxanes induces anti-tumor synergistic effect in cancer cells.Cancer Research · 2026
6. Predicting Pain Outcomes after Digital Care in Chronic Spinal Pain: the roles of Disability, Work Impairment, and Occupation in a Secondary Analysis of a Prospective Clinical StudyPain Medicine · 2026
7. Phase 1 study of rogocekib in patients with relapsed or refractory hematologic malignanciesBlood Advances · 2025
8. Metabolic labeling kinetics of brain-derived 24S-hydroxycholesterol in blood in multiple sclerosis: Effects of treatment with the remyelinating antibody rHIgM22Multiple Sclerosis Journal - Experimental Translational and Clinical · 2025
9. Flecainide acetate inhalation solution for cardioversion of recent-onset, symptomatic atrial fibrillation: results of the phase 3 RESTORE-1 trialEP Europace · 2025
10. Targeting chromosomally unstable tumors with a selective KIF18A inhibitorNature Communications · 2025
11. Mechanisms of Chemical Atrial Defibrillation by Flecainide and IbutilideJACC. Clinical electrophysiology · 2024
12. A phase I/II, first-in-human study of VLS-1488, an oral KIF18A inhibitor, in patients with advanced cancer.Journal of Clinical Oncology · 2024
13. Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus RhythmJACC. Clinical electrophysiology · 2024
14. Effect of Flecainide and Ibutilide Alone and in Combination to Terminate and Prevent Recurrence of Atrial FibrillationThe Medicine Forum · 2023
15. Selecting the best optimizers for deep learning–based medical image segmentationFrontiers in Radiology · 2023
16. KaryoTap Enables Cost-Effective High-Throughput Single-Cell Aneuploidy Profiling and Reveals How Positive and Negative Selection Shapes Cancer Genomes2023
17. Non-cell-autonomous cancer progression from chromosomal instabilityNature · 2023
18. Data from Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma2023
19. The Clinical Development of Levodopa Inhalation PowderClinical Neuropharmacology · 2023
20. Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancerNature Communications · 2023